302 / 671
Example of liver metastases SBRT
• Progress in technology allows
for better targeting, better
management tumor motions,
high dose gradient
• Whole spectrum of lesions
including metastases
not
accesible for surgery
• SABR for oligometastatic
comparable to surgery, 5yOS
49 vs 41% (p=0.43)
• No added mortality:
grade 3
toxic effects often reported in 1-
10% of patients
CK treatment 4
liver metastases
Courtesy
A. Skrobala,
WCO
JK 35/49